NR4A1 and breast cancer: Initiated in 2003, recruitment to a randomized, international, breast cancer trial, which was studying the effects of surgical timing during the menstrual phase on disease-free survival in women with hormone receptor positive breast cancer, was expanded through a blinded SSRE procedure.